William Greene

William Greene, MD, is the Chief Investment Officer (CIO) at Hevolution Foundation, a non-profit organization focused on advancing research and entrepreneurship in healthspan science. He was appointed to this role on December 21, 2022, after serving as an advisor since May 2022. In his position, Dr. Greene oversees the foundation's investment strategy, planning, analysis, and execution.13

Professional Background

Dr. Greene has extensive experience in the life sciences sector, having held various leadership roles including:

• CEO of Fountain Therapeutics: A biotechnology company specializing in longevity.
• CEO of Iconic Therapeutics: Led the company through discovery and development phases to a successful sale.
• Managing Director at MPM Capital: Spent 12 years managing biotechnology and medical technology investments.
• Founding Chairman of the Global Health Investment Fund: Collaborated with the Gates Foundation to create an impact-oriented venture fund.13

Earlier in his career, he was an Assistant Professor of Medicine at the University of California, San Francisco (UCSF), where he contributed to clinical trials and strategic initiatives at Genentech.14

Education

Dr. Greene holds a Bachelor of Arts in Biology from Wesleyan University and an MD from UCSF. He has also been a Robert Wood Johnson Clinical Scholar at Yale and a Howard Hughes Medical Institute Research Scholar at the National Institutes of Health (NIH).13

Vision for Hevolution Foundation

In his role at Hevolution, Dr. Greene aims to tackle significant challenges related to unhealthy aging through innovative investments and collaborations within the healthspan sector. He expressed enthusiasm for driving the foundation's investment strategy in partnership with its scientific team.12